RxDoctor Payments Data

Kalkidan Bishu, MD

Interventional Cardiology · Duluth, MNNPI 1881887818

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,710 of the $2,438 with a category attached, or 70.2%. Abbott accounts for 85.1% of it on its own, with 5 other manufacturers making up the rest. 2024 is the largest year on record at $1,890, 5.8 times the $328 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in MN, where the typical reported total is $5,396.

$2,438in general payments, 2019–2025

Across 24 payments — averaging $101.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Boston Scientific$143
  • Edwards Lifesciences$117
  • Medtronic$69
  • Shockwave Medical, Inc$22
  • Angiodynamics, Inc.$12

What the payments were for

  • Travel & lodging$1,71070%
  • Food & beverage$72830%

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,438 in reported general payments places this provider in the 30th percentile of 84 interventional cardiology providers in Minnesota.

See all interventional cardiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$133,026
Medicare patients
1,091
Services billed
1,753

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban176$177,262
CamzyosMavacamten14$97,441
XareltoRivaroxaban79$73,661
Repatha SureclickEvolocumab64$54,630
JardianceEmpagliflozin43$38,293
EntrestoSacubitril/Valsartan21$22,812
Praluent PenAlirocumab15$15,568
BrilintaTicagrelor15$12,573
Repatha SyringeEvolocumab12$6,464
Metoprolol Succinate292$4,449
Atorvastatin Calcium333$3,799
Isosorbide Mononitrate ErIsosorbide Mononitrate171$2,679
Torsemide86$2,574
Ezetimibe111$2,245
Amiodarone Hcl72$1,910

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Duluth

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →